Regeneron and Sanofi pull Libtayo’s application for cervical cancer treatment
FRANCE – Regeneron Pharmaceuticals Inc and its partner Sanofi voluntarily withdrew their...
Read MoreSelect Page
by Editor | Jan 31, 2022 | Government, Regulatory & Policy News, Hospitals, LATEST NEWS, WORLD NEWS | 0
FRANCE – Regeneron Pharmaceuticals Inc and its partner Sanofi voluntarily withdrew their...
Read Moreby Editor | Jan 10, 2022 | Government, Regulatory & Policy News, Hospitals, LATEST NEWS, WORLD NEWS | 0
UNITED KINGDOM – Merk & Co’s checkpoint inhibitor Keytruda, which has been available for three...
Read Moreby Editor | Nov 19, 2021 | Government, Regulatory & Policy News, Hospitals, LATEST NEWS, WORLD NEWS | 0
USA – US Food and Drug Administration (USFDA) has approved Merck & Co.’s immunotherapy...
Read Moreby Editor | Oct 31, 2021 | Hospitals, LATEST NEWS, WORLD NEWS | 0
USA- Gilead Sciences has tagged Merck in a study where Trodelvy (sacituzumab govitecan), a Trop-2...
Read Moreby Editor | Oct 26, 2021 | Hospitals, LATEST NEWS, WORLD NEWS | 0
SWITZERLAND – Novartis has announced that the primary endpoints of a Phase 3 trial evaluating...
Read Moreby Editor | Oct 14, 2021 | Diseases News, Government, Regulatory & Policy News, Hospitals, LATEST NEWS, WORLD NEWS | 0
USA – The Food and Drug Administration (FDA) has given a positive nod to abemaciclib (Verzenio) in...
Read More